Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 21Unknown 5Active not recruiting 5Terminated 4Recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Estradiol × Clear all
NCT05716516 2026-05-05

ESTHER

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

NCT05900895 2025-11-20

PHOEBE

Dartmouth-Hitchcock Medical Center

Phase 1 Recruiting
6 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03401047 2025-08-05

CRM009

University of Virginia

Phase EARLY_PHASE1 Recruiting
37 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡